main-img
Back to Home » July 2016 News » CFN Media Examines Medical Marijuana, Inc.'s Investment in Exclusive Cannabinoid Patent Licenses

CFN Media Examines Medical Marijuana, Inc.'s Investment in Exclusive Cannabinoid Patent Licenses

July 07, 2016

SEATTLE, WA--(Marketwired - Jul 6, 2016) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article and interview discussing the potential impact of two exclusive patent licenses for cannabinoid (CBD) commercialization on Medical Marijuana, Inc. (OTC PINK: MJNA).

Source URL: http://www.marketwired.com/mw/release.do?id=2140190&sourceType=3
Browse News